These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2649148)

  • 1. Effects of fusidic acid on staphylococcal keratitis.
    Tabbara KF; Antonios S; Alvarez H
    Br J Ophthalmol; 1989 Feb; 73(2):136-9. PubMed ID: 2649148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections.
    Portier H
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():39-44. PubMed ID: 2179203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus epidermidis keratitis treated with vancomycin.
    Goodman DF; Gottsch JD
    Arch Ophthalmol; 1988 Nov; 106(11):1570-1. PubMed ID: 3190543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci.
    Coombs RR; Menday AP
    Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE; Espaze EP; Coste-Burel M; Richet H
    Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis.
    Hedberg A; Hårdemark HG; Olsson-Liljequist B; Sjölin J
    Clin Microbiol Infect; 2004 Aug; 10(8):765-8. PubMed ID: 15301684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences with fusidic acid in cystic fibrosis patients.
    Jensen T; Lanng S; Faber M; Rosdahl VT; Høiby N; Koch C
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():45-52. PubMed ID: 2312445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusidic acid as a potential antistaphylococcal agent.
    Nicholson J; Chew T; Smith S
    N Z Med J; 1999 Jul; 112(1091):261-2. PubMed ID: 10448991
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases.
    Menday AP; Marsh BT
    Curr Med Res Opin; 1976; 4(2):132-8. PubMed ID: 1277881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
    Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
    Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
    Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Staphylococcal Cassette Chromosome (SCC) mec Element Types in Fusidic Acid-Resistant Staphylococcus epidermidis and Identification of a Novel SCC7684 Element.
    Chen HJ; Lin YT; Hung WC; Tsai JC; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5006-9. PubMed ID: 27161629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusidic acid in staphylococcal bone and joint infection.
    Coombs RR
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():53-60. PubMed ID: 2179204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological studies in the therapy of treatment-resistant staphylococcal infections with fusidic acid].
    Roser H
    Med Welt; 1967 May; 21():1325-9. PubMed ID: 5612546
    [No Abstract]   [Full Text] [Related]  

  • 18. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
    Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
    McLaws F; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of fusidic acid in combination with various antibiotics against Staphylococcus epidermidis].
    Fosse T; Appert A; Delpech D; Laffont C
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):621-5. PubMed ID: 3054737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.